Can Positive Framing Reduce Nocebo Side Effects? Current Evidence and Recommendation for Future Research.
adverse health outcomes
attribute framing
expectancies
framing
nocebo
placebo
side effects
verbal suggestion
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
27
11
2018
accepted:
11
02
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
22
3
2019
Statut:
epublish
Résumé
Although critical for informed consent, side effect warnings can contribute directly to poorer patient outcomes because they often induce negative expectations that trigger nocebo side effects. Communication strategies that reduce the development of nocebo side effects whilst maintaining informed consent are therefore of considerable interest. We reviewed theoretical and empirical evidence for the use of framing strategies to achieve this. Framing refers to the way in which information about the likelihood or significance of side effects is presented (e.g., negative frame: 30%
Identifiants
pubmed: 30894815
doi: 10.3389/fphar.2019.00167
pmc: PMC6414427
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
167Références
Lancet. 2001 Oct 13;358(9289):1237-8
pubmed: 11675064
JAMA. 2002 Feb 6;287(5):622-7
pubmed: 11829702
Br J Clin Psychol. 1992 Sep;31 ( Pt 3):301-6
pubmed: 1393159
Risk Anal. 2004 Apr;24(2):311-22
pubmed: 15078302
J Health Commun. 2006;11(1):61-74
pubmed: 16546919
J Neurosci. 2006 Nov 15;26(46):12014-22
pubmed: 17108175
J Sex Med. 2007 Nov;4(6):1708-12
pubmed: 17655657
Curr Opin Anaesthesiol. 2007 Oct;20(5):435-9
pubmed: 17873596
J Health Commun. 2007 Oct-Nov;12(7):623-44
pubmed: 17934940
J R Soc Med. 2008 Sep;101(9):447-53
pubmed: 18779246
Br J Psychol. 2009 Aug;100(Pt 3):603-17
pubmed: 19017432
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Drug Saf. 2009;32(10):837-49
pubmed: 19722727
Ann Behav Med. 2010 Aug;40(1):3-14
pubmed: 20387022
Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):405-15
pubmed: 21442687
Am J Drug Alcohol Abuse. 2011 Sep;37(5):367-75
pubmed: 21854279
Psychosom Med. 2011 Sep;73(7):598-603
pubmed: 21862825
Ann Behav Med. 2012 Feb;43(1):101-16
pubmed: 21993844
Am J Bioeth. 2012;12(3):22-9
pubmed: 22416745
CMAJ. 1990 Jan 15;142(2):127-30
pubmed: 2295029
J Psychopharmacol. 2012 Dec;26(12):1540-7
pubmed: 22992377
Ann Thorac Surg. 2013 Jan;95(1):9-11
pubmed: 23272824
Postgrad Med J. 2013 Sep;89(1055):540-6
pubmed: 23842213
J Behav Med. 2015 Apr;38(2):273-83
pubmed: 25119580
BMC Fam Pract. 2014 Oct 02;15:163
pubmed: 25277783
J Adv Nurs. 2015 Jul;71(7):1518-29
pubmed: 25702534
J Pain. 2015 Oct;16(10):995-1004
pubmed: 26168876
Pain. 2015 Sep;156(9):1589-600
pubmed: 26291997
Am J Bioeth. 2015;15(10):17-9
pubmed: 26479094
Pharmacol Res Perspect. 2016 Mar 17;4(2):e00208
pubmed: 27069627
Health Psychol. 2016 Dec;35(12):1334-1355
pubmed: 27657801
Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):731-741
pubmed: 28176407
Am J Bioeth. 2017 Jun;17(6):46-48
pubmed: 28537825
J Pain. 2018 May;19(5):476-486
pubmed: 29269281
Int Rev Neurobiol. 2018;138:81-93
pubmed: 29681336
Int J Behav Med. 2018 Aug;25(4):381-389
pubmed: 29785686
Ann Behav Med. 2018 May 31;52(7):560-570
pubmed: 29860362
Annu Rev Psychol. 2019 Jan 4;70:599-625
pubmed: 30110575
Int Rev Neurobiol. 2018;139:159-190
pubmed: 30146046
Ann Behav Med. 2018 Sep 10;:null
pubmed: 30204841
Health Psychol Rev. 2018 Dec;12(4):419-436
pubmed: 30205757
Patient Educ Couns. 2019 Mar;102(3):602-603
pubmed: 30243771
Ann Behav Med. 2018 Oct 22;52(11):920-929
pubmed: 30346496
PLoS One. 2019 Jan 3;14(1):e0209851
pubmed: 30605458
Clin Pharmacol Ther. 1987 Sep;42(3):250-3
pubmed: 3621780
Behav Res Ther. 1986;24(1):1-8
pubmed: 3947307
Science. 1981 Jan 30;211(4481):453-8
pubmed: 7455683
J Clin Epidemiol. 1996 Nov;49(11):1271-6
pubmed: 8892495
Acad Med. 1998 May;73(5):538-40
pubmed: 9609869
Organ Behav Hum Decis Process. 1998 Nov;76(2):149-188
pubmed: 9831520